A
Arcus Biosciences, Inc. (RCUS)
NYQ – Real vaqt narxi. Valyuta: USD
31.00
+0.75 (2.48%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
31.36
+0.36 (1.16%)
Bozordan keyin: Jun 26, 2026, 5:57 PM EDT
Find any stock by ticker or company name

NYQ – Real vaqt narxi. Valyuta: USD
31.00
+0.75 (2.48%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
31.36
+0.36 (1.16%)
Bozordan keyin: Jun 26, 2026, 5:57 PM EDT
This stock has a consensus price target of $36.50 based on the ratings of 18 analysts. The high is $70.00 and the low is $14.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 14 | $ 36.5 | $ 70 |
| O’zgarish | -42.41% | 50.14% | 187.95% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-06-04 | 85.56% | LifeSci Capital | $46 | Initiates Coverage On | Outperform |
| 2026-05-18 | 41.19% | Truist Securities | $30 → $35 | Assumes | Buy |
| 2026-05-11 | -11.25% | Morgan Stanley | $20 → $22 | Maintains | Equal-Weight |
| 2026-05-07 | 37.15% | Goldman Sachs | $30 → $34 | Maintains | Buy |
| 2026-04-02 | 65.39% | Wedbush | $37 → $41 | Maintains | Outperform |